CTLA-4 correlates with immune and clinical characteristics of glioma
CTLA-4 is a well-studied immune checkpoint protein that negatively regulates T cell-mediated immune responses. However, the expression of CTLA-4 in glioma and the effects of CTLA-4 on prognosis in patients wit...
20:7
Cancer Cell International 2020
No hay comentarios:
Publicar un comentario